Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 105 participants.
Also called NCT01496430
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT01496430 -
U1111-1125-1197
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01496430. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-05 (actual). Results posted on 2015-05-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
- Condition
- Hypertension
- Condition
- Diabetes
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Azilsartan medoxomil
- Intervention (Drug)
- Azilsartan medoxomil
- Lead sponsor
- Takeda
Record details
- Record id
cardio:ct-nct01496430- Content hash
23c6f5e2dc20c1a869059f8f588e259e21ec5c2e14570822756dbd8869c6542c